Publications by authors named "Tsun Tsun Stacia Chun"
Background: Anticipating the postoperative pathological stage and potential for adverse features of prostate cancer (PCa) patients before radical prostatectomy (RP) is crucial for guiding perioperative treatment.
Methods: A cohort consisting of three sub-cohorts with a total of 709 patients has been enlisted from two major tertiary medical centres in China. The primary assessment parameters for adverse pathological features in this study are the pathological T stage, the AJCC prognostic stage groups and perineural invasion (PNI).
Background: The status of prostate-specific antigen (PSA) screening is unclear in China. Evidence regarding the optimal frequency and interval of serial screening for prostate cancer (PCa) is disputable.
Objective: This study aimed to depict the status of PSA screening and to explore the optimal screening frequency for PCa in China.
Objective: Early evidence is disputable for the effects of modifiable lifestyle behaviors on prostate cancer (PCa) risk. No research has yet appraised such causality in different ancestries using a Mendelian randomization (MR) approach.
Methods: A two-sample univariable and multivariable MR analysis was performed.
Background: Telomerase reverse transcriptase () has been consistently associated with prostate cancer (PCa) risk. However, few studies have explored the association between variants and PCa aggressiveness.
Methods: Individual and genetic data were obtained from UK Biobank and a Chinese PCa cohort (Chinese Consortium for Prostate Cancer Genetics).
Background And Objective: Urine culture is time consuming, which may take days to get the results and impede further timely treatment. Our objective is to evaluate whether the fast urinalysis and bacterial discrimination system called Sysmex UF-5000 may predict urinary tract infections (UTIs) (within minutes) compared with the clinical routine test in suspected UTI patients. In addition, we aimed to explore the accuracy of microbiologic information by UF-5000.
View Article and Find Full Text PDFArticle Synopsis
- A study analyzed the long-term survival outcomes of 782 Chinese prostate cancer patients who underwent radical prostatectomy (RP) from 1998 to 2022 at Queen Mary Hospital.
- The 5-year, 10-year, and 15-year overall survival rates were reported as 96.6%, 86.8%, and 70.6%, while the prostate cancer-specific survival rates were 99.7%, 98.6%, and 97.8%, respectively.
- Key findings indicated that higher Surgical ISUP grade (≥4) and factors like lymph node invasion and extracapsular extension correlated with poorer cancer-specific survival, but different surgical methods showed no significant differences in outcomes.